Welcome to our dedicated page for Cinemark Hldgs SEC filings (Ticker: CNK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cinemark Holdings, Inc. (NYSE: CNK) SEC filings page on Stock Titan provides centralized access to the company’s U.S. regulatory disclosures, along with AI-powered tools to help interpret them. As one of the largest motion picture exhibitors in the world, Cinemark uses filings such as Forms 8-K, 10-Q and 10-K to report on its theater operations, financing arrangements and material corporate events.
Recent Form 8-K filings illustrate the types of information investors can expect to find. Cinemark has filed current reports describing quarterly financial results, a share repurchase program authorized by its board of directors, amendments to its Second Amended and Restated Credit Agreement, and warrant unwind and termination agreements related to its convertible notes. Other 8-Ks reference dividends declared by the board and press releases announcing achievements in specific periods.
On this page, users can track these and other filings in real time as they are posted to the SEC’s EDGAR system. AI-powered summaries highlight the key points of lengthy documents, helping readers quickly identify items such as changes to revolving credit facilities, interest rate adjustments on term loans, or details of repurchase authorizations. For periodic reports like Forms 10-K and 10-Q, AI tools can surface information on Cinemark’s theater count, geographic footprint, revenue sources such as box office and concessions, and risk factor discussions.
In addition, this page offers convenient access to ownership and insider transaction reports, including Form 4 filings when applicable, so users can monitor equity awards and other stock-related activity by directors and officers. By combining the raw SEC documents with automated explanations, the CNK filings page helps investors, analysts and other interested readers better understand how Cinemark manages its capital structure, responds to market conditions and documents material events affecting its theatrical exhibition business.
Cinemark Holdings (CNK) reported Q3 2025 results. Revenue was $857.5 million, down from $921.8 million a year ago. Operating income was $114.4 million. Net income attributable to Cinemark was $49.5 million, or diluted EPS of $0.40, compared with $187.8 million and $1.19 in the prior-year quarter.
For the first nine months of 2025, revenue reached $2,338.7 million and net income attributable to Cinemark was $104.1 million. The quarter included a $54.5 million loss on warrants within other expense. Cash and cash equivalents were $461.3 million at September 30, 2025, versus $1,057.3 million at December 31, 2024, reflecting financing actions and working capital.
Cinemark repaid $460.0 million of 4.50% Senior Convertible Notes, repurchased $200.0 million of common stock year-to-date, issued shares upon maturity of the convertibles and warrant settlements, and paid quarterly dividends of $0.08 per share. Long-term debt was $1,869.6 million, with $6.4 million current. Shares outstanding were 116,507,174 at September 30, 2025; as of October 31, 2025, 117,475,902 shares were outstanding.
Cinemark Holdings (CNK) announced that its Board approved a new share repurchase program authorizing the buyback of up to $300 million of common stock. The program begins on November 7, 2025 and will continue until the authorized amount is reached or the Board suspends or terminates it.
Repurchases may occur through open market purchases, privately negotiated transactions, or under a Rule 10b5-1 trading plan, with timing and volume determined by management based on market conditions and the stock price. The company plans to fund repurchases with available liquidity.
Cinemark states the program aims to pursue opportunistic buybacks and mitigate dilution from equity awards and the early settlement of its warrants. Separately, the company furnished a press release with financial results for the quarter ended September 30, 2025 as Exhibit 99.1.
Cinemark Holdings, Inc. and Cinemark USA, Inc. filed a Current Report on Form 8-K disclosing a Fourth Amendment, dated September 5, 2025, to their Second Amended and Restated Credit Agreement originally dated May 26, 2023. The amendment follows three prior amendments (May 28, 2024; November 29, 2024; June 30, 2025) and names Barclays Bank PLC as administrative agent. The filing is signed by Michael D. Cavalier, Executive Vice President - General Counsel and Business Affairs & Secretary. The document identifies the parties as Cinemark Holdings, Inc., Cinemark USA, Inc., various lenders and agents, and Barclays Bank PLC. No specific financial terms, covenant changes, borrowing amounts, maturity changes or other economic details are included in the disclosed text.
Melissa Thomas, EVP and Chief Financial Officer of Cinemark Holdings, Inc. (CNK), reported an automatic sale of common stock under a Rule 10b5-1 trading plan. On 08/15/2025 she disposed of 7,200 shares at a weighted average price of $25.17 per share, leaving her with 203,768 shares beneficially owned. The Form 4 notes the 10b5-1 plan was adopted on September 4, 2024, so the sale occurred pursuant to pre-established instructions. The filing was signed by attorney-in-fact Michael Cavalier on 08/18/2025.
Cinemark Holdings, Inc. (CNK) filed a Form 8-K reporting a material event that includes an exhibit: a Warrant Unwind and Termination Agreement dated August 15, 2025. The filing identifies the registrant, its Delaware incorporation, SEC file number, principal address in Plano, Texas, and that Common Stock (CNK) is listed on the New York Stock Exchange. The document is signed by Michael D. Cavalier and dated August 18, 2025. The 8-K lists Exhibit 10.1 as the form(s) of the Warrant Unwind and Termination Agreement but does not disclose the agreement's terms, financial impact, counterparties, or other substantive transaction details.
Cinemark Holdings, Inc. (CNK) Form 144 filing for proposed sale of shares by an insider. The filing shows a proposed sale of 7,200 common shares through Charles Schwab & Co., Inc. on 08/15/2025, with an aggregate market value of $181,246.00 and total shares outstanding listed as 115,035,514. The securities were acquired via restricted stock lapses: 3,309 shares on 02/23/2023 and 3,891 shares on 02/20/2024, both identified as equity compensation from Cinemark Holdings, Inc. The filer previously sold 7,200 shares on 05/15/2025 yielding $226,340.00. The notice includes the signer’s representation about lack of undisclosed material adverse information.
Cinemark Holdings, Inc. is the subject of a Schedule 13G/A disclosing that Orbis Investment Management Limited and Allan Gray Australia Pty Ltd together beneficially own 10,098,174 shares of common stock, representing 8.8% of the class. Orbis reports sole voting and dispositive power over 10,045,947 shares while Allan Gray reports sole voting and dispositive power over 52,227 shares.
The filing classifies both reporting persons as non-U.S. institutions equivalent to investment advisers and states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. The reporting persons expressly disclaim being a group and disclaim beneficial ownership of each other’s shares.
Cinemark Holdings, Inc. reported that its Board of Directors has declared a dividend that will be paid during the third quarter of 2025. The Current Report states the announcement is summarized in a press release attached as Exhibit 99.1 titled "2Q25 Dividend Release," and the filing also includes a Cover Page Interactive Data File as Exhibit 104.
The filing does not state the dividend amount, the specific payment or record dates, the source of funds, or any related financial impact, and it includes no financial statements or earnings disclosure. The document identifies the companys common stock trading as CNK on the New York Stock Exchange and shows the emerging-growth-company checkbox as unchecked. Because key dividend terms are absent from this report, readers must consult the attached press release for complete details.
Form 4 filing for Cinemark Holdings (CNK) discloses that Chief Marketing & Content Officer Wanda Marie Gierhart sold 1,254 common shares on 1 Aug 2025 at $28.49 per share, a transaction value of roughly $35.7 k. The sale was executed automatically under a Rule 10b5-1 plan adopted 13 Mar 2025, limiting discretionary timing. After the trade, Gierhart still owns 92,754 shares, so only ~1.3 % of her holdings were liquidated. No derivative securities were involved.
The modest size relative to her remaining stake and the use of a pre-set trading plan suggest limited informational signal for investors. The filing does not indicate any change in role or additional corporate events.